Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 5
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Mischlinger, Johannes Agnandji, Selidji T and Ramharter, Michael 2016. Single dose treatment of malaria - current status and perspectives. Expert Review of Anti-infective Therapy, Vol. 14, Issue. 7, p. 669.


    Turner, Helen 2016. Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4. Future Medicinal Chemistry, Vol. 8, Issue. 2, p. 227.


    Held, Jana Jeyaraj, Sankarganesh and Kreidenweiss, Andrea 2015. Antimalarial compounds in Phase II clinical development. Expert Opinion on Investigational Drugs, Vol. 24, Issue. 3, p. 363.


    Kumar, Sushil Kumari, Renu and Pandey, Richa 2015. New insight-guided approaches to detect, cure, prevent and eliminate malaria. Protoplasma, Vol. 252, Issue. 3, p. 717.


    Manjunatha, Ujjini H. and Smith, Paul W. 2015. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening. Bioorganic & Medicinal Chemistry, Vol. 23, Issue. 16, p. 5087.


    ×

Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages

  • PAUL W. SMITH (a1), THIERRY T. DIAGANA (a1) and BRYAN K. S. YEUNG (a1)
  • DOI: http://dx.doi.org/10.1017/S0031182013000747
  • Published online: 10 June 2013
Abstract
SUMMARY

The number of novel antimalarial candidates entering preclinical development has seen an increase over the last several years. Most of these drug candidates were originally identified as hits coming from screening large chemical libraries specifically targeting the asexual blood stages of Plasmodium falciparum. Indeed, a large proportion of the current antimalarial arsenal has mainly targeted the asexual blood stage which is responsible for clinical symptoms of the disease. However, as part of the eradication agenda and to address resistance, any next-generation antimalarial should have additional activity on at least one other parasite life stage, i.e. gametocytocidal and/or tissue schizonticidal activity. We have applied this approach by screening compounds with intrinsic activity on asexual blood stages in assays against sexual and liver stages and identified two new antimalarial chemotypes with activity on multiple parasite life stages. This strategy can be expanded to identify other chemical classes of molecules with similar activity profiles for the next generation antimalarials. The following review summarizes the discovery of the spiroindolones and imidazolopiperazine classes of antimalarials developed by the NGBS consortium (Novartis Institute for Tropical Diseases, Genomic Institute of the Novartis Research Foundation, Biomedical Primate Research Center, and the Swiss Tropical and Public Health Institute) currently in clinical trials.

Copyright
Corresponding author
*Corresponding author. Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Chromos, Singapore138670. Tel: (+65) 6722 2923. Fax: (+65) 6722 2918. E-mail: bryan.yeung@novartis.com
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M. P. Anthony , J. N. Burrows , S. Duparc , J. J. Moehrle and T. N. C. Wells (2012). The global pipeline of new medicines for the control and elimination of malaria. Malaria Journal 11, 316340. doi:10.1186/1475-2875-11-316.

R. Chattopadhyay , S. Velmurugan , C. Chakiath , L. Andrews Donkor , W. Milhous , J. W. Barnwell , W. E. Collins and S. L. Hoffman (2010). Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax Malaria. PLoS ONE 5, e14275. doi:10.1371/journal.pone.0014275.

I. H. Cheeseman , B. A. Miller , S. Nair , S. Nkhoma , A. Tan , J. C. Tan , S. Al Saai , A. P. Phyo , C. L. Moo , K. M. Lwin , R. McGready , E. Ashley , M. Imwong , K. Stepniewska , P. Yi , A. M. Dondorp , M. Mayxay , P. N. Newton , N. J. White , F. Nosten , M. T. Ferdig and T. J. Anderson (2012). A major genome region underlying artemisinin resistance in malaria. Science 336, 7982.

F. B. Cogswell (1992). The hypnozoite and relapse in primate malaria. Clinical Microbiology Reviews 5, 2635.

M. Delves , D. Plouffe , C. Scheurer , S. Meister , S. Wittlin , E. A. Winzeler , R. E. Sinden and D. Leroy (2012). The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Medicine 9, e1001169. doi:10.1371/journal.pmed.1001169.

L. Dembele , A. Gego , A.-M. Zeeman , J.-F. Franetich , O. Silvie , A. Rametti , R. Le Grand , N. Dereuddre-Bosquet , R. Sauerwein , G.-J. van Gemert , J.-C. Vaillant , A. W. Thomas , G. Snounou , C. H. M. Kocken and D. Mazier (2011). Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS ONE 6, e18162. doi:10.1371/journal.pone.0018162.

E. R. Derbyshire , M. Prudencio , M. M. Mota and J. Clardy (2012). Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proceedings of the National Academy of Sciences, USA 109, 85118516. doi:10.1073/pnas.1118370109.

A. E. Dubin , N. Nasser , J. Rohrbacher , A. N. Hermans , R. Marrannes , C. Grantham , K. Van Rossem , M. Cik , S. R. Chaplan , D. Gallacher , J. Xu , A. Guia , N. G. Byrne and C. Mathes (2005). Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp. Journal of Biomolecular Screening 10, 168181.

W. A. Guiguemde , A. A. Shelat , J. F. Garcia-Bustos , T. T. Diagana , F.-J. Gamo and R. K. Guy (2012). Global phenotypic screening for antimalarials. Chemistry and Biology 19, 116129. doi:10.1016/j.chembiol.2012.01.004.

W. Huber and J. A. Koella (1993). Comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Tropica 55, 257261.

M. C. Jonikas , S. R. Collins , V. Denic , E. Oh , E. M. Quan , V. Schmid , J. Weibezahn , B. Schwappach , P. Walter , J. S. Weissman and M. Schuldiner (2009). Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science 323, 16931697. doi:10.1126/science.1167983

S. Krishna , C. Woodrow , R. Webb , J. Penny , K. Takeyasu , M. Kimura and J. M. East (2001). Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. Journal of Biological Chemistry 276, 1078210787.

Y. Y. Lau , G. Krishna , N. P. Yumibe , D. E. Grotz , E. Sapidou , L. Norton , I. Chu , C. Chen , A. D. Soares and C. C. Lin (2002). The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios. Pharmaceutical Research 19, 16061610.

J. Lelievre , M. J. Almela , S. Lozano , C. Miguel , V. Franco , D. Leroy and E. Herreros (2012). Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence ‘transmission blocking’ assay. PLoS ONE 7, e35019. doi:10.1371/journal.pone.0035019.

B. Liu , J. Chang , W. P. Gordon , J. Isbell , Y. Zhou and T. Tuntland (2007). Snapshot PK: a rapid rodent in vivo preclinical screening approach. Drug Discovery Today 13, 360367. doi:10.1016/j.drudis.2007.10.014.

I. Maeda , Y. Kohara , M. Yamamoto and A. Sugimoto (2001). Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Current Biology 11, 171176.

B. Malleret , C. Claser , A. S. Ong , R. Suwanarusk , K. Sriprawat , S. W. Howland , B. Russell , F. Nosten and L. Renia (2011). A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Scientific Reports 1, 118128. doi:10.1038/srep00118.

C. Mathes (2006). QPatch: the past, present and future of automated patch clamp. Expert Opinions on Therapeutic Targets 10, 319327.

R. J. Maude , W. Pontavornpinyo , S. Saralamba , R. Aguas , S. Yeung , A. M. Dondorp , N. P. Day , N. J. White and L. J. White (2009). The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malaria Journal 8, 3137.

S. Meister , D. M. Plouffe , K. L. Kuhen , G. M. C. Bonamy , T. Wu , S. W. Barnes , S. E. Bopp , R. Borboa , A. T. Bright , J. Che , S. Cohen , N. V. Dharia , K. Gagaring , M. Gettayacamin , P. Gordon , T. Groessl , N. Kato , M. C. S. Lee , C. W. McNamara , D. A. Fidock , A. Nagle , T. G. Nam , W. Richmond , J. Roland , M. Rottmann , B. Zhou , P. Froissard , R. J. Glynne , D. Mazier , J. Sattabongkot , P. G. Schultz , T. Tuntland , J. R. Walker , Y. Zhou , A. Chatterjee , T. T. Diagana and E. A. Winzeler (2011). Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334, 13721377. doi:10.1126/science.1211936.

T. Nam , C. W. McNamara , S. Bopp , N. V. Dharia , S. Meister , G. M. C. Bonamy , D. M. Plouffe , N. Kato , S. McCormack , B. Bursulaya , H. Ke , A. B. Vaidya , P. G. Schultz and E. A. Winzeler (2011). A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor. ACS Chemical Biology 6, 12141222.

H. Noedl , Y. Se , K. Schaecher , B. L. Smith , D. Socheat and M. M. Fukuda (2008). Evidence of artemisinin-resistant malaria in western Cambodia. New England Journal of Medicine 359, 26192620.

A. P. Phyo , S. Nkhoma , K. Stepniewska , E. A. Ashley , S. Nair , R. McGready , C. ler Moo , S. Al-Saai , A. M. Dondorp , K. M. Lwin , P. Singhasivanon , N. P. Day , N. J. White , T. J. Anderson and F. Nosten (2012). Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379, 19601966.

D. Plouffe , A. Brinker , C. McNamara , K. Henson , N. Kato , K. Kuhen , A. Nagle , F. Adrian , J. T. Matzen , P. Anderson , T. G. Nam , N. S. Gray , A. Chatterjee , J. Janes , S. F. Yan , R. Trager , J. S. Caldwell , P. G. Schultz , Y. Zhou and E. A. Winzeler (2008). In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proceedings of the National Academy of Sciences, USA 105, 90599064.

M. Rottmann , C. McNamara , B. K. S. Yeung , M. C. S. Lee , B. Zou , B. Russell , P. Seitz , D. M. Plouffe , N. V. Dharia , J. Tan , S. B. Cohen , K. R. Spencer , G. E. González-Páez , S. B. Lakshminarayana , A. Goh , R. Suwanarusk , T. Jegla , E. K. Schmitt , H.-P. Beck , R. Brun , F. Nosten , L. Renia , V. Dartois , T. H. Keller , D. A. Fidock , E. A. Winzeler and T. T. Diagana (2010). Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 11751180.

B. Russell , R. Suwanarusk , B. Malleret , F. T. M. Costa , G. Snounou , J. K. Baird , F. Nosten and L. Rénia (2012). Human ex vivo studies on asexual Plasmodium vivax: the best way forward. International Journal for Parasitology 42, 10631070.

N. J. Spillman , R. J. Allen , C. W. McNamara , B. K. S. Yeung , E. A. Winzeler , T. T. Diagana and K. Kirk (2013). Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host and Microbe 13, 227237. doi: 10.1016/j.chom.2012.12.006.

T. N. C. Wells (2011). Natural products as starting points for future anti-malarial therapies: going back to our roots? Malaria Journal 10, S3.

T. Wu , A. Nagle , K. Kuhen , K. Gagaring , R. Borboa , C. Francek , Z. Chen , D. Plouffe , A. Goh , S. B. Lakshminarayana , J. Wu , H. Q. Ang , P. Zeng , M. L. Kang , W. Tan , M. Tan , N. Ye , X. Lin , C. Caldwell , J. Ek , S. Skolnik , F. Liu , J. Wang , J. Chang , C. Li , T. Hollenbeck , T. Tuntland , J. Isbell , C. Fischli , R. Brun , M. Rottmann , V. Dartois , T. Keller , T. Diagana , E. Winzeler , R. Glynne , D. C. Tully and A. K. Chatterjee (2011). Imidazolopiperazines: hit to lead optimization of new antimalarial agents. Journal of Medicinal Chemistry 54, 51165130.

J. C. van Pelt-Koops , H. E. Pett , W. Graumans , M. van der Vegte-Bolmer , G. J. van Gemert , M. Rottmann , B. K. S. Yeung , T. T. Diagana and R. W. Sauerwein (2012). The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrobial Agents and Chemotherapy 56, 35443548. doi: 10.1128/AAC.06377-11.

E. A. Winzeler , D. D. Shoemaker , A. Astromoff , H. Liang , K. Anderson , B. Andre , R. Bangham , R. Benito , J. D. Boeke , H. Bussey , A. M. Chu , C. Connelly , K. Davis , F. Dietrich , S. W. Dow , M. El Bakkoury , F. Foury , S. H. Friend , E. Gentalen , G. Giaever , J. H. Hegemann , T. Jones , M. Laub , H. Liao , N. Liebundguth , D. J. Lockhart , A. Lucau-Danila , M. Lussier , N. M'Rabet , P. Menard , M. Mittmann , C. Pai , C. Rebischung , J. L. Revuelta , L. Riles , C. J. Roberts , P. Ross-MacDonald , B. Scherens , M. Snyder , S. Sookhai-Mahadeo , R. K. Storms , S. Veronneau , M. Voet , G. Volckaert , T. R. Ward , R. Wysocki , G. S. Yen , K. Yu , K. Zimmermann , P. Philippsen , M. Johnston and R. W. Davis (1999). Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901906. doi:10.1126/science.285.5429.901.

L. Yatime , M. J. Buch-Pedersen , M. Musgaard , J. P. Morth , A. M. Lund Winther , B. P. Pedersen , C. Olesen , J. P. Andersen , B. Vilsen , B. Schiøtt , M. G. Palmgren , J. V. Møller , P. Nissen and N. Fedosova (2009). P-type ATPases as drug targets: tools for medicine and science. Biochimica et Biophysica Acta 1787, 207220.

B. K. S. Yeung , B. Zou , M. Rottmann , S. B. Lakshminarayana , S. H. Ang , S. H. Leong , J. Tan , J. Wong , S. Keller-Maerki , C. Fischli , A. Goh , E. K. Schmitt , P. Krastel , E. Francotte , K. Kuhen , D. Plouffe , K. Henson , T. Wagner , E. A. Winzeler , F. Petersen , R. Brun , V. Dartois , T. T. Diagana and T. H. Keller (2010). Spirotetrahydro β-carbolines (spiroindolones): A new class of potent and orally efficacious compounds for the treatment of malaria. Journal of Medicinal Chemistry 53, 51555164.

W. Zheng , R. H. Spencer and L. Kiss (2004). High throughput assay technologies for ion channel drug discovery. Assays and Drug Development Technologies 2, 543552.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Parasitology
  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: